CD73-Positive Cell Spheroid Transplantation Attenuates Colonic Atrophy

Daisuke Hisamatsu, Natsumi Itakura, Yo Mabuchi, Rion Ozaki, Eriko Grace Suto, Yuna Naraoka, Akari Ikeda, Lisa Ito, Chihiro Akazawa

研究成果: ジャーナルへの寄稿学術論文査読

1 被引用数 (Scopus)

抄録

The incidence of inflammatory bowel diseases (IBD) is increasing worldwide. Mesenchymal stem/stromal cells (MSCs) have immunomodulatory functions and are a promising source for cell transplantation therapy for IBD. However, owing to their heterogeneous nature, their therapeutic efficacy in colitis is controversial and depends on the delivery route and form of transplanted cells. Cluster of differentiation (CD) 73 is widely expressed in MSCs and used to obtain a homogeneous MSC population. Herein, we determined the optimal method for MSC transplantation using CD73+ cells in a colitis model. mRNA sequencing analysis showed that CD73+ cells exhibited a downregulation of inflammatory gene expression and an upregulation of extracellular matrix-related gene expression. Furthermore, three-dimensional CD73+ cell spheroids showed enhanced engraftment at the injured site through the enteral route, facilitated extracellular matrix remodeling, and downregulated inflammatory gene expression in fibroblasts, leading to the attenuation of colonic atrophy. Therefore, the interaction between intestinal fibroblasts and exogenous MSCs via tissue remodeling is one mechanism that can be exploited for colitis prevention. Our results highlight that the transplantation of homogeneous cell populations with well-characterized properties is beneficial for IBD treatment.

本文言語英語
論文番号845
ジャーナルPharmaceutics
15
3
DOI
出版ステータス出版済み - 03-2023
外部発表はい

All Science Journal Classification (ASJC) codes

  • 薬科学

フィンガープリント

「CD73-Positive Cell Spheroid Transplantation Attenuates Colonic Atrophy」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル